| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And CFO
1 company
Shallcross Steven A is a CEO And CFO at Theriva Biologics, Inc.. Recent SEC Form 4 filings include 9 buys and 0 sells.
Estimated insider holdings value: $81K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2023 | TOVX Theriva Biologics, Inc. | CEO And CFO | Buy | 14,000 | $0.69 | $9,703.40 | +5.9% | -26.7% | -61.9% | |
| Jun 6, 2023 | TOVX Theriva Biologics, Inc. | CEO And CFO | Buy | 26,000 | $0.63 | $16,452.80 | +12.4% | -19.6% | -56.4% | |
| Feb 10, 2023 | TOVX Theriva Biologics, Inc. | CEO And CFO | Buy | 25,000 | $1.04 | $26,075.00 | +13.5% | -33.8% | -49.5% | |
| Feb 2, 2023 | TOVX Theriva Biologics, Inc. | CEO And CFO | Buy | 25,000 | $0.94 | $23,512.50 | +15.6% | -31.9% | -45.7% | |
| Jan 25, 2023 | TOVX Theriva Biologics, Inc. | CEO And CFO | Buy | 25,000 | $0.87 | $21,825.00 | +18.5% | -19.3% | -50.9% | |
| Jan 20, 2023 | TOVX Theriva Biologics, Inc. | CEO And CFO | Buy | 25,000 | $0.75 | $18,705.00 | +22.7% | -7.1% | -45.7% | |
| Dec 29, 2022 | TOVX Theriva Biologics, Inc. | CEO And CFO | Buy | 100,000 | $0.44 | $43,700.00 | +1,000% | +47.8% | -6.5% | |
| May 10, 2021 | TOVX Theriva Biologics, Inc. | CEO And CFO | Buy | 50,000 | $0.49 | $24,595.00 | +100.0% | +7.2% | -51.0% | |
| Aug 23, 2019 | TOVX Theriva Biologics, Inc. | CEO And CFO | Buy | 50,000 | $0.42 | $20,785.00 | New | - | - |